About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health, and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on Twitter, Facebook, Instagram, YouTube, and LinkedIn .

Drug Product Pilot Plant, Tech Ops Overview

Envision spending your summer working with energetic colleagues and inspirational leaders, all while gaining world-class experience in one of the most dynamic organizations in the pharmaceutical industry. This is a reality for AbbVie’s Experiential Interns.

The Drug Product Pilot Plant is part of the Clinical Drug Supply organization within R&D Development Sciences. The Pilot Plant is responsible for supporting formulation development and scale up activities and for manufacturing oral dosage forms (tablets, capsules, granules, solutions) used in phase I to phase IV clinical trials. The Technical Operations (Tech Ops) team is the key support group to keep the Pilot Plant running, with responsibilities including engineering projects, manufacturing process support and troubleshooting, and calibrations and maintenance of both the equipment and the facility. The Tech Ops Intern will gain valuable experience with industry standard unit operations (such as compression, coating, blending, encapsulation) and will build understanding of what it takes to support a state-of-the-art pharmaceutical manufacturing facility.

Key responsibilities include:

• Lead an effort to focus on sustainability in the pilot plant with projects such as energy assessments for purified water generation technologies and analysis of manufacturing waste streams
• Develop KPI metrics and dashboards that track progress toward sustainability goals
• Commission and qualify newly purchased equipment for GMP manufacturing
• Create a plan for managing and organizing manufacturing equipment change parts
• Assist, when necessary, with investigating and troubleshooting equipment and facility issues; recommend and implement solutions

Minimum Qualifications

• Currently enrolled in university, pursuing a Bachelor’s in chemical engineering, mechanical engineering, electrical engineering or other related field.
• Expected graduation date between December 2024 to July 2025.
• Good verbal and written communication skills. Good computer knowledge and good working knowledge of MS Word, Excel.
• Ability to take initiative to handle small to medium complexity projects autonomously.

Preferred Qualifications

• Exposure to process engineering, industrial sustainability, process/system controls, physics, unit operations, manufacturing, mechanics

Benefits and Amenities

• Competitive pay
• Travel, transportation, and lodging support for eligible students
• Opportunity to connect with AbbVie leaders and scientists
• Exposure to cutting edge technologies and concepts presented by AbbVie scientists

Equal Employment Opportunity

At AbbVie, we value bringing together individuals from diverse backgrounds to develop new and innovative solutions for patients. As an equal opportunity employer we do not discriminate on the basis of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information gender identity or expression, sexual orientation, marital status, protected veteran status, or any other legally protected characteristic .

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.